Clinical Trial Update: A Study to Find Out if Daridorexant is Safe and Efficacious in Patients With Insomnia and Comorbid Nocturia [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating the safety and efficacy of daridorexant in patients with insomnia disorder and nocturia has completed, and the study results have bee…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia
• Nocturia

Drugs mentioned

• Daridorexant (daridorexant)

Snippet

Sponsor: Idorsia Pharmaceuticals Ltd. | Conditions: Insomnia Disorder, Nocturia | Phase 4 | Status: COMPLETED | Results posted: 2025-04-18